ADHD - Xconomy

by in

Entry	Author	Date	Location
Tris Pharma Benefits from Pfizer/NextWave Deal	Catherine Arnst	10/30/12	New York
East Coast Life Sciences Roundup: Pfizer, Rhythm, NPS, More	Catherine Arnst	10/26/12	Boston
Pfizer to Acquire NextWave for $700 Million	Catherine Arnst	10/22/12	New York
Neurovance Raises $7 Million for ADHD Drug Development	Catherine Arnst	10/19/12	Boston
In Boston Life Sciences News: Akili, Kala, And Genocea	Erin Kutz	03/16/12	Boston
Drugs that Melt in Your Mouth: MonoSolRx Has Its Sights Set on Oral Insulin	Arlene Weintraub	05/11/11	New York
Prexa Pulls In $7M From Advent, Shire	Erin Kutz	05/11/11	Boston
Clinical Data’s Billionaire Chairman a Major Player in Firm’s Newly FDA-Approved Antidepressant	Ryan McBride	01/25/11	Boston
Hospital-Backed Partners VC Fund Finds Deals Close to Home—Here’s the Early List	Ryan McBride	12/02/08	Boston
Page 1 of 1

Xconomy National